Inventor
BANG-ANDERSEN BENNY
DK44 patents
⚠️ This page may combine multiple inventors who share the name “BANG-ANDERSEN BENNY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUNDBECK & CO AS H
28 patentsUS7144884B2Dec 5, 2006
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H42 citations95
US7138407B2Nov 21, 2006
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H41 citations95
US7772240B2Aug 10, 2010
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
LUNDBECK & CO AS H56 citations94
US8969355B2Mar 3, 2015
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment
LUNDBECK & CO AS H15 citations92
US7648991B2Jan 19, 2010
Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
LUNDBECK & CO AS H29 citations92
US7148238B2Dec 12, 2006
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H23 citations92
US6262087B1Jul 17, 2001
Indane or dihydroindole derivatives
LUNDBECK & CO AS H16 citations92
US9125908B2Sep 8, 2015
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
LUNDBECK & CO AS H11 citations91
US9125909B2Sep 8, 2015
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
LUNDBECK & CO AS H9 citations91
US9125910B2Sep 8, 2015
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
LUNDBECK & CO AS H9 citations91
US7674912B2Mar 9, 2010
Pro-drugs of N-thiazol-2-yl-benzamide derivatives
LUNDBECK & CO AS H22 citations90
US7767683B2Aug 3, 2010
Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament
LUNDBECK & CO AS H18 citations89
US9090575B2Jul 28, 2015
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H5 citations82
US7732463B2Jun 8, 2010
4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H13 citations81
US7683053B2Mar 23, 2010
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
LUNDBECK & CO AS H4 citations73
US6552044B2Apr 22, 2003
Indane or dihydroindole derivatives
LUNDBECK & CO AS H5 citations73
US6352988B2Mar 5, 2002
Indane or dihydroindole derivatives
LUNDBECK & CO AS H5 citations73
US9315459B2Apr 19, 2016
Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine
LUNDBECK & CO AS H4 citations71
US7223765B2May 29, 2007
4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
LUNDBECK & CO AS H2 citations63
US7074796B2Jul 11, 2006
4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
LUNDBECK & CO AS H3 citations63
US6743809B2Jun 1, 2004
Indole Derivatives useful for the treatment of CNS disorders
LUNDBECK & CO AS H4 citations62
US6200999B1Mar 13, 2001
3-Alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
LUNDBECK & CO AS H4 citations59
US7910613B2Mar 22, 2011
2-acylaminothiazole derivatives
LUNDBECK & CO AS H4 citations57
US7276508B2Oct 2, 2007
Indole derivatives useful for the treatment of CNS disorders
LUNDBECK & CO AS H0 citations52
US7105543B2Sep 12, 2006
4-, 5-, 6- and 7-indole derivatives useful for the treatment of CNS disorders
LUNDBECK & CO AS H0 citations52
US6958338B2Oct 25, 2005
4-,5-,6-and 7-indole derivatives useful for the treatment of CNS disorders
LUNDBECK & CO AS H0 citations52
US6890916B2May 10, 2005
Indole derivatives useful for the treatment of CNS disorders
LUNDBECK & CO AS H0 citations52
US7544685B2Jun 9, 2009
2,3-dihydroindole compounds
LUNDBECK & CO AS H0 citations44
H LUNDBECK AS
6 patentsUS10258617B2Apr 16, 2019
Dosing regimens for fast onset of antidepressant effect
H LUNDBECK AS1 citations69
US9913839B2Mar 13, 2018
Dosing regimens for fast onset of antidepressant effect
H LUNDBECK AS2 citations69
US9820984B1Nov 21, 2017
Dosing regimens for fast onset of antidepressant effect
H LUNDBECK AS2 citations69
US9708280B2Jul 18, 2017
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
H LUNDBECK AS1 citations62
US10844029B2Nov 24, 2020
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
H LUNDBECK AS0 citations51
US12391650B2Aug 19, 2025
Catecholamine prodrugs for use in the treatment of Parkinson's disease
H LUNDBECK AS0 citations50
BANG-ANDERSEN BENNY
4 patentsUS8722684B2May 13, 2014
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
BANG-ANDERSEN BENNY31 citations94
US8476279B2Jul 2, 2013
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
BANG-ANDERSEN BENNY16 citations92
US8299095B2Oct 30, 2012
Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition and uses thereof
BANG-ANDERSEN BENNY8 citations81
US8450324B2May 28, 2013
Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
BANG-ANDERSEN BENNY0 citations51